KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Depreciation & Amortization (CF) (2016 - 2025)

Jazz Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $9.4 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $9.4 million for Q4 2025, down 0.91% from a year ago — trailing twelve months through Dec 2025 was $41.6 million (up 27.12% YoY), and the annual figure for FY2025 was $41.6 million, up 27.12%.
  • Depreciation & Amortization (CF) for Q4 2025 was $9.4 million at Jazz Pharmaceuticals, down from $9.9 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for JAZZ hit a ceiling of $11.9 million in Q2 2025 and a floor of $4.8 million in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $7.7 million (2023), compared with a mean of $8.1 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 61.6% in 2021 and later dropped 2.99% in 2023.
  • Jazz Pharmaceuticals' Depreciation & Amortization (CF) stood at $7.3 million in 2021, then grew by 0.23% to $7.3 million in 2022, then rose by 4.14% to $7.6 million in 2023, then grew by 24.4% to $9.5 million in 2024, then dropped by 0.91% to $9.4 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $9.4 million (Q4 2025), $9.9 million (Q3 2025), and $11.9 million (Q2 2025) per Business Quant data.